AAREYDRUGS.NSAAREYDRUGS.NSNSE
Loading
EV to Sales HistoryNormalizing
Percentile Rank29
3Y CAGR+7.6%
5Y CAGR-6.1%
Studio
Year-over-Year Change

Enterprise value to sales ratio

3Y CAGR
+7.6%/yr
vs -6.2%/yr prior
5Y CAGR
-6.1%/yr
Recent acceleration
Acceleration
+13.8pp
Accelerating
Percentile
P29
Within normal range
vs 5Y Ago
0.7x
Contraction
Streak
1 yr
Consecutive declineNormalizing
PeriodValueYoY Change
20250.29-22.0%
20240.37+58.2%
20230.23+1.0%
20220.23-32.2%
20210.34-13.8%
20200.40+19.8%
20190.33+10.7%
20180.30+34.7%
20170.22-36.5%
20160.35-